Successful management of recurrent allergic bronchopulmonary aspergillosis after changing from mepolizumab to dupilumab: A case report.
Respir Med Case Rep
; 39: 101723, 2022.
Article
en En
| MEDLINE
| ID: mdl-36043197
ABPA, Allergic bronchopulmonary aspergillosis; ACT, Asthma Control Test; ANCA, Antineutrophil cytoplasmic antibody; Allergic bronchopulmonary aspergillosis; CT, Computed tomography; Dupilumab; EETosis, Eosinophil extracellular trap cell death; ETosis, Extracellular trap cell death; FEV1, Forced expiratory volume in 1 sec; ICS, Inhaled corticosteroid; IL-13; IL-4; IL-5, Interleukin-5; ILC2, Group-2 innate lymphoid cells; IgE, Immunoglobulin E; LABA, Long-acting beta-agonist; Mepolizumab; PSL, Prednisolone; Prednisolone
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Respir Med Case Rep
Año:
2022
Tipo del documento:
Article
País de afiliación:
Japón